Where real medical voices become your competitive advantage

Healthcare is dynamic—so are we. By listening directly to patients and professionals, we deliver insights that go beyond numbers, turning real voices into smarter strategies for trust, innovation, and growth.

Speak with an expert

Case study: Migraine in Canada — prevalence, awareness, and economic burden

BLANK - DO NOT DELETE

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Objective

Leger Healthcare aimed to understand the prevalence, awareness, and economic burden of migraine in Canada—shedding light on the gap between experiencing symptoms and having an official diagnosis, while quantifying its impact on productivity and society.

Methodology
A nationwide survey conducted by Leger Healthcare explored the personal and societal cost of migraine across Canada—measuring diagnosis rates, the frequency of symptom days among both diagnosed and undiagnosed individuals, and estimating economic consequences in terms of lost productivity.
Outcome
The research revealed:
  • Gender gap: 21% of women diagnosed vs. 8% of men; men seek care less, women face misdiagnosis or underdiagnosis more often.
  • Age gap: 25% of younger adults (18–34) may be undiagnosed, which may be impacting early career productivity.
  • Treatment: 81% with undiagnosed migraine rely on OTC remedies; diagnosed patients access more effective prescriptions.
  • Economic toll: 429M lost work hours = $14.6B annually; over half report work impacts (38% less productive, 20% missed days, 20% left work early, 5% missed deadlines).
Roud our article

Recognizing pharmacists’ expanding role in Canadian healthcare

Pharmacists’ roles now extend beyond dispensing to assessing, prescribing, and managing care, easing pressure on hospitals and physicians. Learn more in our white paper.

Learn more
Read our article

An Economic Cost to Society: Migraine Is Widespread, Misunderstood, And Missed

Migraine isn’t just a headache, it’s a debilitating neurological condition affecting millions of Canadians, many of whom don’t even know they have it. Yet despite its impact, migraine remains a highly misunderstood and underdiagnosed health issue. 

Learn more
Read our article

From insight to impact: How market research fuels pharma creativity

In pharmaceutical marketing, strict regulations can often spark creativity. Market research guides this process, turning insights into campaigns that are impactful and compliant.

Learn more

Meet our experts

Dima Ostrikov

VP, Healthcare
I partner with clients across the product lifecycle to turn complex questions into decision-ready insights that advance patient outcomes. With high-quality data from clinical and patient stakeholders, I deliver clear narratives, practical recommendations, and real-world perspectives backed by analytical rigor.

Stephanie Lander

Associate VP, Healthcare

I support healthcare organizations by providing evidence-based insights into healthcare provider and patient perspectives and needs, driving strategies that enhance engagement and ultimately improve outcomes.

Daniel Ambelez

Associate VP, Healthcare

Clients come to me for expertise in healthcare research across treatment areas such as infectious disease, oncology, diabetes, and respiratory illnesses, helping them turn complex feedback into clear strategies that strengthen brand impact.

Your next business decision starts here.

Behind every dataset, there are people. Our experts and partners share real perspectives to help you succeed.

Speak with an expert

Stay ahead of what’s next.

Subscribe to newsletter